Holdings
General Catalyst Group Management, LLC
As of Jun 30, 2026, General Catalyst Group Management, LLC reported 14 positions worth US$189M. Largest: Arrivent Biopharma, Inc., Parabilis Medicines, Inc. and Maplebear Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Arrivent Biopharma, Inc. | 1.49M | US$51.9M | no change | Jun 30, 2026 |
| Parabilis Medicines, Inc. | 1.6M | US$43.8M | new | Jun 30, 2026 |
| Maplebear Inc. | 711K | US$33.7M | no change | Jun 30, 2026 |
| Maze Therapeutics, Inc. | 1.04M | US$30.9M | no change | Jun 30, 2026 |
| Odyssey Therapeutics, Inc. | 810K | US$15.2M | new | Jun 30, 2026 |
| Eikon Therapeutics, Inc. | 305K | US$3.98M | no change | Jun 30, 2026 |
| Fractyl Health, Inc. | 4.88M | US$3.88M | −7 | Jun 30, 2026 |
| Ethos Technologies Inc. | 74,179 | US$1.35M | no change | Jun 30, 2026 |
| Coupang, Inc. | 54,677 | US$950K | +18,000 | Jun 30, 2026 |
| Amazon.com, Inc. | 3,882 | US$925K | +1,300 | Jun 30, 2026 |